Fas expression on human fetal astrocytes without susceptibility to Fas- mediated cytotoxicity

Neuroscience

Volumn 84, Issue 2, 1998, Pages 627-634

  Becher, B ^a   D'Souza, S D ^a   Troutt, A B ^b   Antel, J P ^a  

^a MCGILL UNIVERSITY   (Canada)

^b AMGEN INC   (United States)

Author keywords

CD95 L; CNS; Fas ligand; Fas(CD95); Human fetal astrocytes

Indexed keywords

ANTIBODY; CELL SURFACE RECEPTOR; CYTOKINE; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 4; LACTATE DEHYDROGENASE; PROPIDIUM IODIDE; RECEPTOR;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

ADULT; ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; ASTROCYTES; BRAIN; CELL MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; DNA FRAGMENTATION; FETUS; HUMANS; NEUROGLIA;

EID: 0031934559     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00455-7     Document Type: Article

References (35)

1. Aggarwal B. B., Singh S., LaPushin R., Totpal K. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. Fedn. Eur. biochem. Socs Lett. 364:1995;5-8.
2. Camerini D., Walz G., Loenen W. A., Borst J., Seed B. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immun. 147:1991;3165-3169.
3. Cascino I., Papoff G., DeMaria R., Testi R., Ruberti G. Fas/APO-1 (CD95) receptor lacking the intracytoplasmic signalling domain protects tumor cells from fas-mediated apoptosis. J. Immun. 156:1996;13-17.
4. Dowling P., Shang C., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. exp. Med. 184:1996;1513-1518.
5. D'Souza S., Alinauskas K., McCrea E., Goodyer C., Antel J. P. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 15:1995;7293-7300.
6. D'Souza S. D., Bonetti B., Balasingam V., Cashman N. R., Barker P. A., Troutt A. B., Raine C. S., Antel J. P. Multiple sclerosis: fas signaling in oligodendrocyte cell death. J. exp. Med. 184:1996.
7. Durkop H., Latza U., Hummel M., Eitelbach F., Seed B., Stein H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell. 68:1992;421-427.
8. Hughes D. P., Crispe I. N. A naturally occurring soluble isoform of murine fas generated by alternative splicing. J. exp. Med. 182:1995;1395-1401.
9. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hare A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen fas can mediate apoptosis. Cell. 66:1991;233-243.
10. Johnson D., Lanahan A., Buck C. R., Sehgal A., Morgan C., Mercer E., Bothwell M., Chao M. C. Expression and structure of the human NGF receptor. Cell. 47:1986;545-554.
11. King L. B., Ashwell J. D. Thymocyte and T cell apoptosis: is all death created equal? Thymus. 23:1994;209-230.
12. Kischkel F. C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P. H., Peter M. E. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins from a death-inducing signalling complex (DISC) with the receptor. Eur. molec. Biol. Org. J. 14:1995;5577-5588.
13. Komada Y., Zhou Y. W., Zhang X. L., Xue H. L., Sakai H., Tanaka S., Sakatoku H., Sakurai M. Fas receptor (CD95)-mediated apoptosis is induced in leukemia cells entering G1B compartment of the cell cycle. Blood. 86:1995;3848-3860.
14. + phenotype and inhibits cell division. J. Neurochem. 64:1995;1800-1807.
15. Li T., Ramirez K., Palacios R. Distinct patterns of fas cell surface expression during development of T- or B-lymphocyte lineages in normal, SCID and mutant mice lacking or overexpressing p53, bcl-2, or RAG-2 genes. Cell Growth Diff. 7:1996;107-114.
16. Loetscher H., Schlaeger E. J., Lahm H. W., Pan Y. C., Lesslauer W., Brockhaus M. Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells. J. biol. Chem. 265:1990;20131-20138.
17. Lynch D. H. Biology of fas. Cir. Shock. 44:1995;63-66.
18. Matsuyama T., Hata R., Tagaya M., Yamamoto Y., Nakajima T., Furuyama J., Wanaka A., Sugita M. Fas antigen mRNA induction in postischemic murine brain. Brain Res. 657:1994;342-346.
19. Natoli G., Ianni A., Costanzo A., DePetrillo G., Ilari I., Chirillo P., Balsano C., Levrero M. Resistance to fas-mediated apoptosis in human hepatoma cells. Oncogene. 11:1995;1157-1164.
20. Nishimura T., Akiyama H., Yonehara S., Kondo H., Ikeda K., Kato M., Iseki E., Kosaka K. Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res. 695:1995;137-145.
21. Ogurihyakumachi N., Takahashi S., Nakagawa T., Kikuchi K. Selective depletion of cycli-dependent kinases is associated with fas-mediated apoptosis in human leukemia T-cell lines. Int. J. Immunopharmac. 17:1995;913-921.
22. Owen-Schaub L. B., Angelo L. S., Radinsky R., Ware C. F., Gesner T. G., Bartos D. P. Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis? Cancer Lett. 94:1995;1-8.
23. Owen-Schaub L. B., Meterissian S., Ford R. J. Fas/APO-1 expression and function on malignant cells of hematologic and non-hematologic origin. J. Immunother. 14:1993;234-241.
24. Panayiotidis P., Ganeshaguru K., Foroni L., Hoffbrand A. V. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia. 9:1995;1227-1232.
25. Rathmell J. G., Goodnow C. C. Autoimmunity. The Fas track. Curr. Biol. 5:1995;1218-1221.
26. Rensing-Ehl A., Hess S., Ziegler-Heitbrock H. W., Riethmuller G., Engelmann H. Fas/APO-1 activates nuclear factor kappa B and induces interleukin-6 production. J. Inflamm. 45:1995;161-174.
27. Rouquet N., Allemand I., Molina T., Bennoun M., Briand P., Joulin V. Fas-dependent apoptosis is impaired by SV40 T antigen in transgenic liver. Oncogene. 11:1995;1061-1067.
28. Schall T. J., Lewis M., Koller K. J., Lee A., Rice G. C., Wong G. H., Gatanaga T., Granger G. A., Lentz R., Raab H. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 61:1990;361-370.
29. Stamenkovic I., Clark E. A., Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. Eur. molec. Biol. Org. J. 8:1989;1403-1410.
30. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
31. Tepper C. G., Jayadev S., Liu B., Bielawska A., Wolff R., Yonehara S., Hannun Y. A., Seldin M. F. Role for ceramide as an endogenous mediator of fas-induced cytotoxicity. Proc. natn. Acad. Sci. U.S.A. 92:1995;8443-8447.
32. Trauth B. C., Klas C., Peters A. M., Matzku S., Moller P., Falk W., Debatin K. M., Krammer P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 245:1989;301-305.
33. Weller M., Frei K., Groscurth P., Krammer P. H., Yonekawa Y., Fontana A. Anti-fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J. clin. Invest. 94:1994;954-964.
34. Yong V. W. and Antel J. P. (1992) Culture of glial cells from human brain biopsies. In Biology and Pathology of Astrocyte-Neuron Interactions (ed. Fedoroff S.), pp. 271-281, Humana, New York.
35. Yong V. W., Tejada-Berges T., Goodyer C. G., Antel J. P., Yong F. P. Differential proliferative response of human and mouse astrocytes to gamma-interferon. Glia. 6:1992;269-280.